Markel (MKL)
Financials · Multi-line Insurance and Diversified Holding Company · NYSE
A holding company combining specialized insurance underwriting with a diverse portfolio of non-insurance businesses and a long-term equity investment strategy.
What Markel does
Markel Group is a diverse financial holding company that operates through three primary segments: insurance, investments, and Markel Ventures. The insurance segment provides specialty insurance products, while the Markel Ventures segment operates a variety of businesses across different industries, including manufacturing, healthcare, and consumer goods. The company leverages its insurance float to invest in a portfolio of fixed maturity securities and equity holdings.
Themes: insurance underwriting, value investing, diversified industrial holdings, float management
Fundamentals
- Price$1,884.10 as of 2026-10-20 close
- Market cap$23.3B as of 2026-07-22 (share count; price 2026-10-20)
- 1-year return-1.2% 2025-10-20 close $1,907.55 → 2026-10-20 close $1,884.10
- P/E10.40 as of 2026-10-20
- Net margin+13.6% FY2025, SEC XBRL
- ROE+11.3% FY2025, SEC XBRL
- ROICn/a No figure: it is a bank or insurer, whose operating income and debt are not what ROIC divides.
- Debt / equity0.23 borrowings, leases excluded / equity — 10-Q/10-K balance sheet 2026-06-30
- Revenue growth (YoY)+4.7% FY2025, SEC XBRL
- Revenue CAGR (3y)+9.9% SEC XBRL
- Beta0.51 as of 2026-09-03
- Last reported earnings2026-02-04 most recent in our data — SEC EDGAR Form 8-K (Item 2.02); no newer announcement filed
Dividend: pays a dividend.
How MKL compares in its sector
- price-to-earnings ratiobottom 25% 487 covered Financials peers, as of 2026-10-20
- net profit marginmiddle range 343 covered Financials peers, as of 2026-09-03
- operating marginmiddle range 121 covered Financials peers, as of 2026-09-03
- return on equitymiddle range 558 covered Financials peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 347 covered Financials peers
- free cash flow (absolute dollars, latest fiscal year)top 10% 430 covered Financials peers, as of FY2025
Position among covered Financials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
MKL is not currently in any published Top 10 list. Its scores are below.
Top 10 score
63.7 #116 of 1,265 scored · #46 of 173 in Financials
Valuation 84th (price to book 1.2, price to earnings 10.4) and capital return 79th (net share count bought back over the year 3); weakest is trend (48th, a "death cross" — its 50-day average is below its 200-day).
Scores as of 20 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Quarterly results
| Quarter | Revenue | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|
| Q2 FY2026 2026-06-30 | $4.0B | $1.6B | $1.2B | $92.76 | $429M† | $44M† |
| Q1 FY2026 2026-03-31 | $3.6B | -$273M | -$212M | -$18.90 | $16M | $47M |
| Q4 FY2025 2025-12-31 | $4.0B† | $795M† | $577M† | $48.62† | $662M† | $63M† |
| Q3 FY2025 2025-09-30 | $3.9B | $1.0B | $751M | $59.25 | $1.2B† | $52M† |
| Q2 FY2025 2025-06-30 | $4.0B | $1.1B | $657M | $49.67 | $504M† | $51M† |
| Q1 FY2025 2025-03-31 | $3.5B | $283M | $122M | $12.08 | $376M | $41M |
| Q4 FY2024 2024-12-31 | $3.7B† | $595M† | $549M† | $38.90† | $494M† | $74M† |
| Q3 FY2024 2024-09-30 | $3.7B | $1.4B | $905M | $66.25 | $891M† | $52M† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-30
- Cash and equivalents$3.4B
- Total debt$4.4B borrowings only; leases excluded
- Net debt$945M total debt − cash − short-term investments
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How Markel looks technically
Markel (MKL) is trading 1.4% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 135 trading days ago — a "death cross", a bearish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 29, with buyers in control. Momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 73, in overbought territory (above 70). It just made a new 20-day high, its first since 2026-08-04, pushing above its recent trading range.
Trend
7
| Distance from the 200-day | it is trading 1.4% below its 200-day average, the long-term trend line — a long-term downtrend | -1.4% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $1790.04 | $1790.04 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $1911.40 | $1911.40 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 19 calendar days ago — the swings before that are what the structure reading is measured on | 19 sessions |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 135 trading days ago — a "death cross", a bearish long-term signal | 135 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 29, with buyers in control | 28.8 |
Momentum
3
| 14-day RSI | momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 73, in overbought territory (above 70) | 73.1 |
|---|---|---|
| Position in its 14-day range | it is trading right at the top of its 14-day range ($1704.17 to $1884.68) — its "stochastic" reading is 100 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 99.7 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 11 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $2207.59 | $2207.59 |
|---|---|---|
| From the 52-week high | it is 14.7% below its 52-week high (its highest price of the past year) | -14.7% |
| Above the 52-week low | it is 10.6% above its 52-week low (its lowest price of the past year) | +10.6% |
| Below the 52-week high | it is 14.7% below its highest point of the past year | 14.7% |
| Since a 20-day breakout | it just made a new 20-day high, its first since 2026-08-04, pushing above its recent trading range | 1 session |
| Since a 55-day breakout | it made a new 55-day low about 15 trading days ago | 15 sessions |
| All-time high | its highest closing price on record is $2207.59 (set on 2025-12-24) | $2207.59 |
| Given back of the 52-week move | over the past year its closes ranged ($1712.45 to $2191.90), and it has recovered roughly a third of its fall from last year’s high — 36% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $2008.75 to $2024.09. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 35.8% |
| From the all-time high | it is 14.7% below its all-time high | -14.7% |
| Nearest price level | it is sitting right on a resistance level at $1891.69 — a price it turned at 9 times since 2025-03-25, most recently on 2026-07-15. Since 2024-10-21 it has 5 such levels below the current price and 6 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +0.4% |
| All-time low | its lowest closing price on record is $208.77 (set on 2009-03-09) | $208.77 |
| Above the all-time low | it is 802.5% above its all-time low | +802.5% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are wider than usual versus its own recent 6-month history (wider than about 72% of it) | 72nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $28.39 between its high and its low — about 1.5% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $28.39 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $1670.86 and $1866.55 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $1670.86 – $1768.70 – $1866.55 |
| Typical daily range (% of price) | its price moves about 1.5% in a typical session — among the calmest in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 1.5% |
| Stretch from the 200-day average | it is trading 1.0 daily range below its 200-day average price (1.4% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.0 daily range below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.79× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 0.9% since the prior reading | +0.9% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating has improved toward "buy" since the prior reading | 0.14 toward buy |
Price gaps
1
| Open gap | it gapped 2.8% below the previous close 57 sessions ago and has not traded back through the level it left behind at 2015 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -2.8% |
|---|
Price streaks
1
| Closing streak | it has closed higher 5 sessions in a row, a +5.3% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 5 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 5.1 percentage points (the stock gained 6.1% while the market gained 1.0%) | +5.1% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 8.4 percentage points (the stock lost 4.8% while the market gained 3.6%) | -8.4% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 12.6 percentage points (the stock lost 4.1% while the market gained 8.5%) | -12.6% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 15.8 percentage points (the stock lost 1.2% while the market gained 14.6%) | -15.8% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a fresh 20-day high, MACD momentum is positive, a strong uptrend, with buyers in control — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, its RSI momentum gauge is overbought (a stretched reading), lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 5 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-14 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is moderate, spanning 5.0% of the share price. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is sitting right on the average price paid so far this year, so the typical buyer over that stretch is roughly break-even. That average is $1884.79 — a volume-weighted average of daily closes over 198 sessions, not a true tick-by-tick VWAP. | -0.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 4% above the average price paid since it last reported on 2026-07-29 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $1803.51 — a volume-weighted average of daily closes over 59 sessions, not a true tick-by-tick VWAP. | +4.5% |
Price levels it has turned at before
MKL last closed at $1884.10 on 2026-10-20. Since 2024-10-21 it has turned at 5 prices below its last close and 6 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $1891.69 | Resistance | 0.4% above the last close | turned there 9 times · 2025-03-25 to 2026-07-15 |
| $1846.76 | Support | 2.0% below the last close | turned there 7 times · 2025-01-27 to 2026-09-03 |
| $1954.94 | Resistance | 3.8% above the last close | turned there 7 times · 2025-03-03 to 2026-03-09 |
| $1803.28 | Support | 4.3% below the last close | turned there six times · 2024-11-27 to 2025-10-29 |
| $1768.93 | Support | 6.1% below the last close | turned there five times · 2024-12-26 to 2026-09-10 |
| $2009.70 | Resistance | 6.7% above the last close | turned there 7 times · 2025-07-07 to 2026-07-07 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-20.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading above the 50-day moving average · Overbought (14-day RSI above 70) · Broke out to a new 20-day high · in a strong, established uptrend (ADX) · lagging the market | Learn: moving average · golden cross · adx · rsi · breakout
Based on daily closing prices as of 2026-10-20. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingHold (3.14 mean, 1=Strong Buy…5=Strong Sell) — 6 analysts
- Mean price target$1,951.50 range $1,532.00 – $2,107.00; median $2,010.00
Analyst estimates, as of 2026-10-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for MKL
- Consensus EPS estimate$27.76 next reporting period, as of 2026-10-17
- Estimate change, 30 days+$0.9047 (+3.4%) from $26.85, on 2026-09-12, 35-day window
- Readings revised upward30% of 10 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Significant exposure to investment market volatility impacting equity portfolio and fixed maturity securities.","Potential for material underwriting losses from catastrophic events in the insurance segment.","Dependence on the performance of diverse, non-insurance subsidiary businesses under Markel Ventures."]
What changed in the latest 10-Q
AI-assisted comparison of MKL's 10-Q filed 2026-04-28 against the prior one filed 2025-10-29.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-04-28) adds 'Recent Developments' subsection under Markel Insurance with reference to 'Middle East Conflict' and mentions of 'U.S. and Israeli airstrikes'
- Newer filing adds reference to '2025 Annual Report on Form 10-K' instead of '2024 Annual Report on Form 10-K'
- Newer filing reorganizes MD&A section structure, removing 'Capital Performance' as a separate section listed in the outline
- Removed:
- Older filing (2025-10-29) includes detailed 'Capital Performance' section with five-year key financial metrics table; newer filing does not include this section
- Older filing explains 'In the third quarter of 2025, we made notable changes to our financial reporting, including the re-segmentation of our businesses'; newer filing omits this explanation
- Older filing includes detailed paragraph on 'An example of Markel Group's long-term mindset is the approach to reserving within the insurance operations' with discussion of reserve practices; newer filing removes this
- Older filing includes detailed section 'The Company's architecture is intentionally designed to promote long-term decision making' with explanations of diverse cash flows, debt levels, and decentralized leadership; newer filing condenses this content
- Older filing includes subsection 'Relentlessly Compounding Shareholder Capital' as a separate heading with four-part investment test details; newer filing integrates this content more briefly into Business Overview
- Reworded:
- Older: 'Markel Group also owns shares in publicly traded companies, primarily within its insurance operations' changes to newer: 'which are primarily held within its insurance operations'
- Older describes The Markel Style as 'built on simple ideas: treat people fairly, act with integrity, and commit to winning over the long term'; newer describes it as 'a shared set of values that foster excellence and consistency' without the specific values enumeration
- Older includes detailed explanation of four investment criteria (good returns on capital, management teams, reinvestment opportunities, fair price); newer condenses to general reference to 'redeploy capital efficiently, with low friction, across a large and diverse opportunity set'
- Newer filing uses 'which are primarily held within its insurance operations' vs older 'primarily within its insurance operations' for publicly traded company holdings
- Notes:
- Newer filing text is truncated at 'Middle East Conflict' section, so full extent of 'Recent Developments' additions cannot be fully assessed
- The comparison reflects Q1 2026 (newer) vs Q3 2025 (older) 10-Q filings with different reporting periods and years referenced, which may explain some structural differences
- MD&A reorganization may reflect standard quarterly update practice rather than substantive change in disclosure approach
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-16. The 5 days since 2026-10-16 have not been checked yet.
- Last 180 days · read to 2026-10-163 buys ($371066) · 3 sells ($140396) — 2 buying, 1 selling insiders
Most recent open-market transaction: 2026-05-22. Based on Form 4 filings read through 2026-10-16; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about MKL's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 28 matched disclosures for MKL from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
5 institutional 13F filers reported holding MKL as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 1,102,930
- Reported value $2,154,031,595
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 2 increased, 3 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about MKL's institutional holders → See what each manager we track holds →
Short interest (FINRA)
MKL had 276,782 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
MKL had 2.23% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.48 days to cover at the same settlement.
- Reported short interest (shares) 276,782
- Short interest (% of shares outstanding) 2.23%
- Prior settlement (shares) 278,703
- Reported change -0.69%
- Days to cover (reported) 3.48
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Berkshire Hathaway
- W. R. Berkley (WRB)
- Arch Capital Group (ACGL)
- Everest Group (EG)
- Travelers Companies (TRV)
- Chubb (CB)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare MKL vs…
Frequently asked questions
What does Markel (MKL) do?
Markel Group is a diverse financial holding company that operates through three primary segments: insurance, investments, and Markel Ventures. The insurance segment provides specialty insurance products, while the Markel Ventures segment operates a variety of businesses across different industries, including manufacturing, healthcare, and consumer goods. The company leverages its insurance float to invest in a portfolio of fixed maturity securities and equity holdings.
What sector is Markel (MKL) in?
Markel (MKL) is classified in the Financials sector. Its industry is Multi-line Insurance and Diversified Holding Company. It trades on NYSE.
Does MKL pay a dividend?
Yes — Markel (MKL) pays a dividend (market data, as of 2026-09-03). Informational only — not financial advice.
Who are Markel's (MKL) competitors?
Notable peers of Markel (MKL) include Berkshire Hathaway, W. R. Berkley, Arch Capital Group, Everest Group and Travelers Companies. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in MKL?
Yes — we hold 28 matched STOCK Act disclosures for MKL from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Markel (MKL) overbought or oversold right now?
Markel (MKL) is currently in overbought territory (its 14-day RSI is 73, above 70) (as of 2026-10-20). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on MKL come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.